HiperScan GmbH develops scanning grating technology and near-infrared (NIR) spectroscopes used for rapid, cost-efficient identification of substances and mixtures. The company has sold over 400 Apo-Ident NIR spectroscopes to German pharmacies. The report states HiperScan raised €450K in funding (the article also notes the amount "was not disclosed"). The company intends to use the funds to continue technical development of its NIR systems, prioritizing miniaturization, cost optimization and scaling. It also plans to expand operations globally. Led by CEO Dr. Alexander Wolter, HiperScan was founded in 2006 as a spin-off of the Dresdner Fraunhofer Institute for Photonic Microsystems (IPMS).

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2013